What about Shandong Runhua Pharmaceutical Co., Ltd.?

Introduction: Shandong Runhua Pharmaceutical Co., Ltd. is a traditional Chinese medicine pharmaceutical enterprise which is controlled by Runhua Group Co., Ltd., integrating scientific research, production and sales. The company has strong strength and assets of over 100 million yuan, and is a high-tech enterprise in Shandong Province under the national "863 Plan" project.

The company is located in Zhangqiu Mingshui Economic Development Zone, Jinan City, and has five production lines (including Chinese medicine extraction workshop) for tablets, mixtures, capsules, granules and oral liquid, all of which have passed GMP certification. At present, the company has the annual production capacity of extracting 2,200 tons of traditional Chinese medicine extracts, producing 654.38+0.5 billion tablets, 654.38+0.00 million bottles of mixture, 300 million capsules, 50 million bags of granules and 654.38+0.00 million tablets of oral liquid.

The "Tuberculous Tablets" developed by the company in cooperation with Shandong University of Traditional Chinese Medicine and Shandong Provincial Hospital of Traditional Chinese Medicine was successfully established as the national "863" plan in April 2004, and passed the acceptance of the Ministry of Science and Technology. The company was awarded the honorary titles of high-tech enterprise, Chinese medicine modernization demonstration enterprise, Jinan enterprise technology center and Jinan key leading enterprise by relevant government agencies. In 2009, the Runhua trademark used by the company was awarded as "Famous Trademark in Shandong Province" and 20 10 was awarded as "Enterprise that values contracts and keeps promises".

As a well-known brand in Shandong, the products of Shandong Runhua Pharmaceutical Co., Ltd. have been recognized by customers for their reliable quality and remarkable curative effect, and sell well in more than ten provinces such as Shandong, Jiangsu, Liaoning and Hebei. Among them, Jinling Ganmao Tablet and Xiaoer Shuangjin Qingre Oral Liquid are exclusive products. Jinling Ganmao Tablet is a national protected variety of traditional Chinese medicine, and Xiaoer Shuangjin Qingre oral liquid is refined from 16 pure Chinese medicine preparation, which has won unanimous praise from consumers for its safety and remarkable curative effect. Hugan Granule and Compound Berberine are listed in the national essential drugs list, while Chuanxinlian Tablet, Hugan Granule, Compound Berberine Tablet and Xinkening Capsule are listed in the national medical insurance list. Jinling Ganmao Tablet, Chuanshu Tablet, Hugan Tablet, Compound Folium Isatidis and Chuanxinlian Tablet have been included in the list of essential drugs for rural doctors in Shandong Province.

At present, the company has nearly 300 employees, accounting for 35% with bachelor degree or above, and has a stable management team and professional scientific research strength.

Shandong Runhua Pharmaceutical Co., Ltd. aims at "revitalizing Chinese medicine, benefiting mankind, being honest and trustworthy, and benefiting the world", based on the pharmaceutical industry, and set foot in the health industry in a timely manner; Based on Shandong market, build a national market, and aim to develop into a professional pharmaceutical enterprise with high profitability and influence in the pharmaceutical industry. And will go to the capital market as soon as possible after a certain accumulation.

Legal Representative: Sun Guangrui

Date of establishment: 1994-05-20

Registered capital: 55 million yuan.

Location: Shandong Province

Unified social credit code: 91370181613207100a.

Business status: in-service (opened) enterprises.

Industry: manufacturing industry

Company type: limited liability company (wholly owned by a legal person invested or controlled by a natural person)

Number of employees: 100-499.

Enterprise Address: Yegongyi Road, Mingshui Economic Development Zone, Zhangqiu City, Jinan City, Shandong Province

Business scope: production and self-sale: oral liquid, tablet, mixture, powder, hard capsule, granule, raw material medicine (montmorillonite) (the validity period is subject to the license); Biotechnology research and development. (Projects subject to approval according to law can only be operated after approval by relevant departments)